CDEX INC Cashflow Statement | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Statements of cash flows

In USD, except per-share amounts

	FY2014 12 months to Oct 31, 2014	FY2013 12 months to Oct 31, 2013	FY2012 12 months to Oct 31, 2012
Cash flows from operating activities:
Losses since inception
Adjustments to reconcile net loss to cash used by operating activities:
Depreciation and amortization
Note discount amortization
Share-based compensation
Shares issued under oncology agreement
Negotiated settlements on accounts payable
Loss recognized on disposal of equipment
Noncash interest expense
Changes in operating assets and liabilities:
Accounts receivable
Inventory
Prepaid expenses and other assets
Proceeds from oncology agreement
Current liabilities
Net cash used by operating activities
Cash flows from investing activities:
Purchase of property and equipment
Net cash used by investing activities
Cash flows from financing activities:
Cash provided primarily through "Administrative Expense" financing
Proceeds received under bankruptcy financing
Repayment of notes payable
Proceeds received under line of credit
Proceeds received under Warrant Exchange offer
Net cash provided by financing activities
Net decrease in cash
Cash, beginning of the year
Cash, end of the year
Cash payments for interest
Cash payments for taxes
Conversion of notes payable and accrued interest to common stock
Warrants issued for Oncology Agreement
Warrant incremental value on renegotiated debt
Conversion of accrued expenses and accounts payable into notes payable
Transfer from deferred costs to fixed assets
Previously unrecognized claims cleared through implementation of Bankruptcy plan
Liabilities resolved through implementation of Bankruptcy plan
Issuance of stock accrued for in prior year
Supplemental Cash Flow Information
Liabilitites resolved through Warrant Exchange offer
Issuance of previously accrued common stock

Comments